Back to search

Czechia· CZ-0255311

ARTESUNATE AMIVAS

A artesunate product containing artesunate, registered in Czechia by Amivas Ireland Ltd, Waterford. The same ATC class is registered in 12 of our 19 countries.

ATC P01BE03

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedARTESUNATE AMIVASATCP01BE03REGISTER NO.CZ-0255311PACKS LISTED0CHECKEDSeptember 28, 2026

Where it is registered

Artesunate is registered in 12 of 19 countries.

Countries holding a registration under ATC P01BE03 (artesunate), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose

Artesunate · ATC P01BE03

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
ARTESUNATE
Manufacturer
Amivas Ireland Ltd, Waterford
Country
Czechia (CZ)
ATC code
P01BE03
ATC class
Artesunate
Defined daily dose
0.28 g, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

106 interactions on record for artesunate.

Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Artesunate · interactions on record

106 records

  • 2 severe
  • 104 moderate

Most severe, free to view

  • EluxadolineA07DA06severe
  • GrazoprevirJ05AP11severe
  • RolapitantA04AD14moderate
  • EliglustatA16AX10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9f47af44-cd09-4221-b1f1-fccf3cb929bb
GET /v1/drugs/9f47af44-cd09-4221-b1f1-fccf3cb929bb?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "INJ PSO LQF",
  "source": "sukl",
  "strength": "110MG",
  "pack_size": "2+2X12ML",
  "substance": "ARTESUNATE",
  "cz_kod_sukl": "0255311",
  "product_type": "CH",
  "substance_codes": "10951",
  "registration_state": "R",
  "registration_number": "EU/1/21/1582/001"
}

See everything about artesunate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.